636 related articles for article (PubMed ID: 30803991)
1. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
Sanz MA; Fenaux P; Tallman MS; Estey EH; Löwenberg B; Naoe T; Lengfelder E; Döhner H; Burnett AK; Chen SJ; Mathews V; Iland H; Rego E; Kantarjian H; Adès L; Avvisati G; Montesinos P; Platzbecker U; Ravandi F; Russell NH; Lo-Coco F
Blood; 2019 Apr; 133(15):1630-1643. PubMed ID: 30803991
[TBL] [Abstract][Full Text] [Related]
2. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Sanz MA; Grimwade D; Tallman MS; Lowenberg B; Fenaux P; Estey EH; Naoe T; Lengfelder E; Büchner T; Döhner H; Burnett AK; Lo-Coco F
Blood; 2009 Feb; 113(9):1875-91. PubMed ID: 18812465
[TBL] [Abstract][Full Text] [Related]
3. [Acute promyelocytic leukemia: state-of-the-art management].
Asou N
Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
[TBL] [Abstract][Full Text] [Related]
5. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.
Breccia M; Foà R
Expert Rev Hematol; 2019 Feb; 12(2):81-87. PubMed ID: 30572725
[TBL] [Abstract][Full Text] [Related]
6. Optimal treatment strategies for high-risk acute promyelocytic leukemia.
Norsworthy KJ; Altman JK
Curr Opin Hematol; 2016 Mar; 23(2):127-36. PubMed ID: 26825698
[TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukemia: what is the new standard of care?
Watts JM; Tallman MS
Blood Rev; 2014 Sep; 28(5):205-12. PubMed ID: 25107311
[TBL] [Abstract][Full Text] [Related]
8. Management of patients with acute promyelocytic leukemia.
Kayser S; Schlenk RF; Platzbecker U
Leukemia; 2018 Jun; 32(6):1277-1294. PubMed ID: 29743722
[TBL] [Abstract][Full Text] [Related]
9. Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia.
Yang S; Ma R; Yuan X; Jiang L; Shi J; Yang J; Lei P; Zang Y; Chen X; Zhang Y; Liu Z; Guo J; Zhang L; Zhu X; Zhu Z
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e382-e391. PubMed ID: 32336675
[TBL] [Abstract][Full Text] [Related]
10. [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO - AML-BFM-Recommendations].
Creutzig U; Dworzak M; von Neuhoff N; Rasche M; Reinhardt D
Klin Padiatr; 2018 Oct; 230(6):299-304. PubMed ID: 30399642
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
12. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
[TBL] [Abstract][Full Text] [Related]
13. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL).
Fujita H; Ishikawa Y; Yokoyama Y
Int J Hematol; 2020 Jun; 111(6):747-760. PubMed ID: 32347422
[No Abstract] [Full Text] [Related]
14. Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation.
Douer D; Hu W; Giralt S; Lill M; DiPersio J
Oncologist; 2003; 8(2):132-40. PubMed ID: 12697938
[TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all.
Stahl M; Tallman MS
Leuk Lymphoma; 2019 Dec; 60(13):3107-3115. PubMed ID: 31842650
[TBL] [Abstract][Full Text] [Related]
16. Differentiation syndrome in acute promyelocytic leukaemia.
Stahl M; Tallman MS
Br J Haematol; 2019 Oct; 187(2):157-162. PubMed ID: 31410848
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
[TBL] [Abstract][Full Text] [Related]
18. Role of hematopoietic cell transplantation in relapsed acute promyelocytic leukemia.
Hashmi H; Nishihori T
Clin Transplant; 2020 Sep; 34(9):e14009. PubMed ID: 32526047
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid.
Nellessen CM; Janzen V; Mayer K; Giovannini G; Gembruch U; Brossart P; Merz WM
Arch Gynecol Obstet; 2018 Feb; 297(2):281-284. PubMed ID: 29110117
[TBL] [Abstract][Full Text] [Related]
20. [Therapies for newly diagnosed acute promyelocytic leukemia].
Yokoyama Y
Rinsho Ketsueki; 2020; 61(9):1166-1173. PubMed ID: 33162512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]